Clinical Evaluation of Radiolabeled Drugs for Tubercular Imaging

by Singh, Namrata
State: New
£65.90
VAT included - FREE Shipping
Singh, Namrata Clinical Evaluation of Radiolabeled Drugs for Tubercular Imaging
Singh, Namrata - Clinical Evaluation of Radiolabeled Drugs for Tubercular Imaging

Do you like this product? Spread the word!

£65.90 incl. VAT
Only 1 items available Only 1 items available
Delivery: between Friday, 3 June 2022 and Tuesday, 7 June 2022
Sales & Shipping: Dodax

Description

Clinical evaluation of radiolabeled drugs for tubercular imaging examines how an early diagnosis of tubercular infection can be done. Early diagnosis of Tuberculosis is a prerequisite for its treatment. This book includes various in vitro, in vivo experiments and Phase I clinical trial done helps us to understand how nuclear medicine modality using 99mTc-INH and 99mTc-EMB as radiotracer can be use for the diagnosis of TB, a major cause of death especially in developing country. In vitro and in vivo uptake of these radiotracers is a positive sign for its diagnostic utility not only for the patients suffering from sensitive tuberculosis but also resistant ones.

Contributors

Author:
Singh, Namrata

Further information

Biography Artist:
Namrata Singh,PhD: Biomedical Sciences from University of Delhi, India. Worked as lecturer in University of Delhi. She has extensive experience as a biomedical researcher and has published many papers and abstracts. She holds a Gold Medal in Biology from the University of Delhi. She also holds a patent. She lives with her husband in Texas, USA
Language:
English
Edition:
1/2010
Number of Pages:
216
Media Type:
Softcover
Publisher:
LAP Lambert Academic Publishing

Master Data

Product Type:
Paperback book
Release date:
9 August 2010
Package Dimensions:
0.22 x 0.15 x 0.012 m; 0.367 kg
GTIN:
09783838378381
DUIN:
EM9DEP458G1
£65.90
We use cookies on our website to make our services more efficient and more user-friendly. Therefore please select "Accept cookies"! Please read our Privacy Policy for further information.